Skip to main content

Table 5 Cox regression analysis on mortality, 3-level definition of corticosteroid treatment, including single comorbidities

From: Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases

 

Adj HR (95% IC)

No GC

Ref

GC ≤ 7.5 mg/day

1.84 (0.90, 3.75)

GC > 7.5 mg/day

1.85 (0.74, 4.65)

Female gender

0.73 (0.40, 1.35)

Age

1.10 (1.06, 1.14)

HAQ

1.09 (0.70, 1.71)

Arterial hypertension

1.13 (0.60, 2.10)

Diabetes

4.59 (2.14, 9.84)

Neoplasm

0.40 (0.05, 2.99)

Myocardial infarction

3.09 (1.04, 9.14)

MTX

0.51 (0.24, 1.09)

ACPA

1.38 (0.63, 3.05)

  1. GC glucocorticoid, HR hazard ratio, CI confidence interval, HAQ Health Assessment Questionnaire, MTX methotrexate, ACPA anti-cyclic citrullinated peptide antibodies